Haycocknema perplexum myositis: the first description of subclinical disease and a proposed distinctive triad to evoke clinical suspicion.
Kayla WardAnirudh KrishnanKrishnan R IyengarThomas RobertsonRichard WhiteRavindra UrkudePublished in: BMJ neurology open (2022)
myositis and the possibility of subclinical infection, which suggests a protracted disease course. Further research is required to identify a non-invasive diagnostic test, given that early diagnosis and timely initiation of albendazole treatment may drastically limit patient disability.